As of 2024-12-12, the Fair Value of Oric Pharmaceuticals Inc (ORIC) is -8.49 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 8.96 USD, the upside of Oric Pharmaceuticals Inc is -194.79%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -26.88 | -73.70 | -78.72 | -89.12 | -100.70 | -73.82 |
| YoY growth | -25.84% | -174.18% | -6.81% | -13.21% | -12.99% | -46.61% |
| Market Cap (mil) | 632.31 |
| P/E | |
| Forward P/E |
| EPS | -1.70 |
| Avg earnings growth rate | -46.61% |
| TTM earnings | -119.87 |